跳至主要内容
临床试验/NCT04673721
NCT04673721已完成不适用

PROSPective Evaluation of Fortified Eggs Related to Improvement in The Biomarker Profile for Your Health

Duke University2 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2021年1月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
140
试验地点
2
主要终点
Change in LDL-cholesterol

研究概览

简要总结

The objective of the study is to assess the effect of fortified eggs (compared to a non-egg supplemented diet) and intermittent fasting (IF) (compared to a usual care diet) on biomarker profile at 4 months. This will be a 140-participant, 2x2 factorial, randomized clinical trial comparing fortified eggs vs. a non-egg supplemented diet and IF vs. usual care diet through 4 months. Participants will be randomized 1:1:1:1 to the four treatment groups. Participants will have in-person follow-up visits at 1- and 4- months (inclusive of laboratory assessments) in addition to telephone calls at months 2 and 3. A subset of patients (~24 in each egg randomized strata) will undergo microbiome assessment at baseline and at 4 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Other
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥ 50 years of age AND
  • At least one of the following two criteria:
  • Prior cardiovascular event (myocardial infarction, coronary revascularization or ischemic stroke) OR
  • 2 cardiovascular risk factors including: 1) Diabetes mellitus (Defined as taking a medication for diabetes OR HgbA1c ≥6.5% within the prior 18 months; patients with diabetes may be treated with medications that are not associated with hypoglycemia such as metformin, thiazolidinediones (TZDs), glucagon-like peptide-1 receptor agonists (GLP-1 RAs), sodium glucose co-transporter 2 (SGLT2) inhibitors and/or dipeptidyl peptidase-4 (DPP-4) inhibitors, 2) Body mass index (BMI) ≥ 30 kg/m2, 3) Hypertension (Defined as taking blood pressure lowering medications OR systolic BP > 140mmHg at screening OR diastolic BP > 90mmHg at screening), 4) Dyslipidemia (Defined as taking lipid lowering medication OR LDL ≥130 OR HDL <50 for women OR HDL <40 for men OR triglycerides ≥150), or 5) Chronic kidney disease (Defined as eGFR <60 on most recent laboratory assessment within prior 18 months)
  • Signed informed consent

排除标准

  • Known allergy or intolerance to eggs
  • Patients with diabetes who are on insulin or insulin secretagogues (e.g., sulfonylureas and meglitinides)
  • Recent cardiovascular event (MI, stroke, HF hospitalization) within the past 30 days
  • Planned initiation/change in lipid therapy within the next 4 months
  • Current daily use of any supplements or multivitamins containing Vitamin B2 (riboflavin), Vitamin B12, Vitamin D, Vitamin E, or selenium or planned initiation within the next 4 months (current users need a 1-month washout period off supplement prior to eligibility)
  • Inability or unwillingness to comply with the study requirements
  • History of heart transplant or left ventricular assist device
  • Pregnant or nursing women
  • Malignancy or other non-cardiac condition limiting life expectancy to <4 months
  • Consumption of > 2 eggs per week (this does not include eggs contained within other foods)
  • Ongoing or recent (prior 30 days) participation in another interventional study

结局指标

主要结局

Change in LDL-cholesterol

时间窗: Baseline, 4 months

Change in HDL-cholesterol

时间窗: Baseline, 4 months

次要结局

  • Change in Vitamin E level(Baseline, 4 months)
  • Change in high-sensitivity troponin (hsTroponin)(Baseline, 4 months)
  • Change in total cholesterol(Baseline, 4 months)
  • Change in Vitamin D level(Baseline, 4 months)
  • Change in triglycerides(Baseline, 4 months)
  • Change in lipoprotein subfractionation(Baseline, 4 months)
  • Change in selenium level(Baseline, 4 months)
  • Change in hemoglobin A1c (HbA1c)(Baseline, 4 months)
  • Change in insulin resistance score (LP-IR)(Baseline, 4 months)
  • Change in apolipoprotein B(Baseline, 4 months)
  • Change in fatty acid profile(Baseline, 4 months)
  • Change in high-sensitivity c-reactive protein (hsCRP)(Baseline, 4 months)
  • Change in NMP LipoProfile(Baseline, 4 months)
  • Change in Vitamin B2 level(Baseline, 4 months)
  • Change in Vitamin B12 level(Baseline, 4 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

PROSPective Evaluation of Fortified Eggs Related to... | 临床试验